ANI Pharmaceuticals マネジメント
マネジメント 基準チェック /24
ANI Pharmaceuticalsの CEO はNikhil Lalwaniで、 Sep2020年に任命され、 の在任期間は 4.17年です。 の年間総報酬は$ 8.08Mで、 9.5%給与と90.5%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の1.91%を直接所有しており、その価値は$ 21.63M 。経営陣と取締役会の平均在任期間はそれぞれ3年と4.2年です。
主要情報
Nikhil Lalwani
最高経営責任者
US$8.1m
報酬総額
CEO給与比率 | 9.5% |
CEO在任期間 | 4.2yrs |
CEOの所有権 | 1.9% |
経営陣の平均在職期間 | 3yrs |
取締役会の平均在任期間 | 4.2yrs |
経営陣の近況
Recent updates
Here's Why ANI Pharmaceuticals (NASDAQ:ANIP) Can Manage Its Debt Responsibly
Nov 09ANI Pharmaceuticals Is Acting Like It Is Being Acquired
Nov 02ANI Pharmaceuticals: A Rare GARP Stock In An Overbought Market
Oct 11There's No Escaping ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Muted Revenues
Sep 10ANI Pharmaceuticals' (NASDAQ:ANIP) Earnings Are Weaker Than They Seem
Aug 14Is ANI Pharmaceuticals (NASDAQ:ANIP) Using Too Much Debt?
Aug 08ANI Pharmaceuticals: Tezruly Just Approved, 2 More NDAs Under Review And Alimera Science Acquisition Could Triple Revenue By 2028
Aug 02Subdued Growth No Barrier To ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Price
Jun 10ANI Pharmaceuticals Is Undervalued, As Royalty Potential Is Overlooked
Jun 10These 4 Measures Indicate That ANI Pharmaceuticals (NASDAQ:ANIP) Is Using Debt Reasonably Well
Feb 17Additional Considerations Required While Assessing ANI Pharmaceuticals' (NASDAQ:ANIP) Strong Earnings
Nov 15Does ANI Pharmaceuticals (NASDAQ:ANIP) Have A Healthy Balance Sheet?
Sep 22Does ANI Pharmaceuticals (NASDAQ:ANIP) Have A Healthy Balance Sheet?
Feb 22We Think ANI Pharmaceuticals (NASDAQ:ANIP) Has A Fair Chunk Of Debt
Oct 28ANI Pharma launches generic Prochlorperazine maleate tablets
Aug 29ANI Pharmaceuticals' generic dexamethasone tablets get FDA approval
Aug 16CEO報酬分析
日付 | 総報酬 | 給与 | 会社業績 |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$9m |
Jun 30 2024 | n/a | n/a | US$24m |
Mar 31 2024 | n/a | n/a | US$31m |
Dec 31 2023 | US$8m | US$764k | US$15m |
Sep 30 2023 | n/a | n/a | US$10m |
Jun 30 2023 | n/a | n/a | -US$8m |
Mar 31 2023 | n/a | n/a | -US$28m |
Dec 31 2022 | US$5m | US$737k | -US$50m |
Sep 30 2022 | n/a | n/a | -US$69m |
Jun 30 2022 | n/a | n/a | -US$65m |
Mar 31 2022 | n/a | n/a | -US$63m |
Dec 31 2021 | US$7m | US$715k | -US$43m |
Sep 30 2021 | n/a | n/a | -US$22m |
Jun 30 2021 | n/a | n/a | -US$17m |
Mar 31 2021 | n/a | n/a | -US$15m |
Dec 31 2020 | US$4m | US$199k | -US$23m |
報酬と市場: Nikhilの 総報酬 ($USD 8.08M ) は、 US市場 ($USD 3.15M ) の同規模の企業の平均を上回っています。
報酬と収益: Nikhilの報酬は増加しましたが、会社は利益を上げていません。
CEO(最高経営責任者
Nikhil Lalwani (46 yo)
4.2yrs
在職期間
US$8,078,353
報酬
Mr. Nikhil Lalwani served as a Director of Association for Accessible Medicines. He served as the Chief Executive Officer of InvaGen Pharmaceuticals, Inc. since October 24, 2016. Mr. Lalwani is a seasoned...
リーダーシップ・チーム
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
President | 4.2yrs | US$8.08m | 1.91% $ 21.6m | |
Senior VP of Finance & CFO | 8.5yrs | US$2.58m | 0.83% $ 9.4m | |
Senior Vice President of Corporate Development & Strategy | 3yrs | US$1.90m | 1.24% $ 14.1m | |
Senior Vp & Head of Rare Disease | 3.8yrs | US$1.91m | 0.39% $ 4.4m | |
Senior Vice President of Generics | 3.8yrs | US$1.94m | 0.40% $ 4.5m | |
Head of R&D | 3yrs | データなし | 0.26% $ 3.0m | |
Senior Vice President of Operations | 8.5yrs | US$1.43m | 0.60% $ 6.8m | |
Chief Compliance Officer & Head of Legal of Rare Disease | 2.8yrs | データなし | データなし | |
Senior VP | 2.3yrs | データなし | 0.29% $ 3.3m | |
Senior VP & Chief Human Resources Officer | 2.2yrs | データなし | 0.26% $ 2.9m | |
Chief Medical Officer | 2.8yrs | データなし | データなし | |
Senior VP & Head of Established Brands | 3yrs | データなし | 0.17% $ 1.9m |
3.0yrs
平均在職期間
51.5yo
平均年齢
経験豊富な経営陣: ANIPの経営陣は 経験豊富 であると考えられます ( 3年の平均在職年数)。
取締役
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
President | 4.2yrs | US$8.08m | 1.91% $ 21.6m | |
Head of R&D | 3yrs | データなし | 0.26% $ 3.0m | |
Independent Chairman | 6.5yrs | US$422.21k | 0.38% $ 4.3m | |
Independent Director | 4.3yrs | US$393.25k | 0.16% $ 1.8m | |
Independent Director | 6.5yrs | US$412.21k | 0.26% $ 3.0m | |
Independent Director | 4.3yrs | US$395.75k | 0.21% $ 2.3m | |
Independent Director | 2.7yrs | US$392.37k | 0.12% $ 1.3m | |
Independent Director | 1.3yrs | US$470.76k | 0.061% $ 693.9k |
4.2yrs
平均在職期間
61.5yo
平均年齢
経験豊富なボード: ANIPの 取締役会 は 経験豊富 であると考えられます ( 4.2年の平均在任期間)。